Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Mark Boguniewicz

Concepts (542)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dermatitis, Atopic
169
2026
322
24.900
 Why?
Antibodies, Monoclonal, Humanized
25
2026
1005
3.070
 Why?
Eczema
14
2023
66
2.870
 Why?
Severity of Illness Index
53
2026
2973
2.110
 Why?
Antibodies, Monoclonal
10
2025
1514
2.020
 Why?
Skin
34
2024
759
1.760
 Why?
Tacrolimus
20
2023
196
1.610
 Why?
Biological Products
3
2024
258
1.590
 Why?
Asthma
19
2025
1805
1.500
 Why?
Pruritus
17
2026
60
1.460
 Why?
Dermatologic Agents
14
2024
69
1.370
 Why?
Quality of Life
31
2025
3246
1.350
 Why?
Staphylococcus aureus
15
2024
458
1.300
 Why?
Practice Guidelines as Topic
11
2025
1598
1.250
 Why?
Staphylococcal Skin Infections
8
2018
40
1.210
 Why?
Immunosuppressive Agents
15
2024
840
1.190
 Why?
Double-Blind Method
29
2025
2080
1.070
 Why?
Keratinocytes
12
2024
249
1.000
 Why?
Receptors, Aryl Hydrocarbon
2
2024
61
0.970
 Why?
Calcineurin Inhibitors
14
2010
69
0.870
 Why?
Immunoglobulin E
19
2024
316
0.850
 Why?
Kaposi Varicelliform Eruption
12
2013
21
0.850
 Why?
Humans
188
2026
147293
0.840
 Why?
Treatment Outcome
35
2026
11947
0.700
 Why?
Cytokines
17
2024
2086
0.680
 Why?
Boron Compounds
3
2018
29
0.680
 Why?
Administration, Topical
17
2026
156
0.680
 Why?
Urticaria
3
2008
38
0.660
 Why?
Hypersensitivity
3
2023
254
0.660
 Why?
Emollients
4
2018
11
0.660
 Why?
Interleukin-4 Receptor alpha Subunit
1
2020
9
0.650
 Why?
Adrenal Cortex Hormones
11
2023
487
0.640
 Why?
Intermediate Filament Proteins
7
2018
57
0.630
 Why?
Janus Kinase Inhibitors
3
2025
28
0.620
 Why?
Allergy and Immunology
2
2017
43
0.580
 Why?
Bandages
3
2016
41
0.580
 Why?
Bridged Bicyclo Compounds, Heterocyclic
3
2018
293
0.580
 Why?
Dermatology
3
2017
132
0.570
 Why?
Anti-Infective Agents
5
2022
234
0.570
 Why?
Expert Testimony
1
2019
43
0.560
 Why?
Anti-Inflammatory Agents
11
2020
481
0.550
 Why?
Skin Care
4
2008
22
0.550
 Why?
Interleukin-13
11
2025
149
0.540
 Why?
Adult
77
2025
41405
0.540
 Why?
Antimicrobial Cationic Peptides
6
2010
81
0.540
 Why?
Interferon-gamma
11
2013
786
0.540
 Why?
Food Hypersensitivity
6
2024
168
0.530
 Why?
Biological Therapy
1
2017
28
0.520
 Why?
Occlusive Dressings
1
2016
7
0.500
 Why?
Psoriasis
12
2023
115
0.480
 Why?
Aminopyridines
3
2026
129
0.480
 Why?
Benzamides
3
2026
227
0.470
 Why?
Anti-Asthmatic Agents
1
2019
264
0.470
 Why?
Interleukin-4
9
2023
207
0.460
 Why?
Phosphodiesterase 4 Inhibitors
2
2026
12
0.460
 Why?
Herpes Simplex
3
2013
102
0.450
 Why?
Comorbidity
8
2025
1672
0.450
 Why?
Advisory Committees
1
2017
233
0.450
 Why?
Child, Preschool
34
2026
12016
0.440
 Why?
Desensitization, Immunologic
5
2024
91
0.430
 Why?
Education, Medical, Continuing
1
2016
134
0.420
 Why?
Epidermis
3
2017
156
0.420
 Why?
Cost of Illness
9
2018
327
0.420
 Why?
beta-Defensins
8
2010
22
0.410
 Why?
Adolescent
39
2025
22825
0.400
 Why?
Simplexvirus
3
2011
82
0.400
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
3
2018
15
0.400
 Why?
Glycyrrhetinic Acid
3
2008
7
0.400
 Why?
Conjunctivitis
3
2023
30
0.400
 Why?
Th2 Cells
6
2017
179
0.390
 Why?
Child
44
2024
22979
0.390
 Why?
Anti-Allergic Agents
3
2014
41
0.390
 Why?
Administration, Cutaneous
10
2026
127
0.380
 Why?
Molecular Targeted Therapy
2
2020
444
0.380
 Why?
Hypersensitivity, Immediate
3
2019
41
0.380
 Why?
Autoimmune Diseases
4
2018
471
0.370
 Why?
Calcineurin
5
2006
106
0.370
 Why?
Histamine H1 Antagonists
3
2026
24
0.360
 Why?
Male
60
2026
73950
0.350
 Why?
Immunity, Innate
6
2011
840
0.330
 Why?
Allergens
7
2023
391
0.330
 Why?
Anti-Inflammatory Agents, Non-Steroidal
4
2015
347
0.330
 Why?
Histamine Antagonists
2
2026
21
0.320
 Why?
Drug Approval
3
2020
93
0.310
 Why?
Ointments
10
2016
25
0.310
 Why?
Female
58
2026
80076
0.310
 Why?
Adaptive Immunity
1
2011
171
0.310
 Why?
Plant Extracts
3
2008
191
0.300
 Why?
Clinical Trials as Topic
4
2020
1072
0.290
 Why?
Infant
24
2024
10194
0.290
 Why?
Complementary Therapies
1
2010
96
0.290
 Why?
Staphylococcal Infections
4
2023
395
0.290
 Why?
Dietary Fats
2
2008
309
0.290
 Why?
Off-Label Use
2
2020
51
0.280
 Why?
Methicillin-Resistant Staphylococcus aureus
1
2012
251
0.280
 Why?
Drug Hypersensitivity
3
1995
93
0.280
 Why?
Disease Progression
6
2019
2890
0.280
 Why?
Receptors, IgE
1
2008
43
0.280
 Why?
Population Groups
2
2018
56
0.280
 Why?
Chronic Disease
12
2019
1844
0.260
 Why?
Prevalence
12
2019
2889
0.260
 Why?
Biomarkers
8
2024
4351
0.260
 Why?
Middle Aged
39
2025
36821
0.260
 Why?
Inflammation
4
2018
2920
0.260
 Why?
Disease Management
5
2020
654
0.260
 Why?
Self Report
7
2019
887
0.250
 Why?
Pyrimidines
4
2024
532
0.250
 Why?
United States
20
2024
16313
0.240
 Why?
Sulfonamides
4
2023
596
0.240
 Why?
Rhinitis, Allergic
2
2024
42
0.240
 Why?
Chemokine CCL17
2
2024
6
0.230
 Why?
Consensus
3
2024
476
0.230
 Why?
Dermatitis, Allergic Contact
2
2016
74
0.220
 Why?
Vaccinia virus
4
2011
35
0.220
 Why?
Cross-Sectional Studies
14
2021
6011
0.220
 Why?
Patch Tests
3
2016
61
0.220
 Why?
Omalizumab
2
2020
44
0.220
 Why?
Sphingosine N-Acyltransferase
1
2024
6
0.210
 Why?
Anti-Bacterial Agents
6
2023
1940
0.210
 Why?
Phototherapy
3
2018
50
0.210
 Why?
Steroids
3
2017
162
0.210
 Why?
Exanthema
1
2005
86
0.210
 Why?
Diagnosis, Differential
7
2008
1518
0.200
 Why?
Ectropion
1
2023
1
0.200
 Why?
Pyrazoles
2
2024
518
0.190
 Why?
Janus Kinases
1
2023
21
0.190
 Why?
Randomized Controlled Trials as Topic
7
2026
1776
0.190
 Why?
Down-Regulation
7
2017
618
0.190
 Why?
Membrane Proteins
5
2024
1171
0.190
 Why?
Blepharitis
1
2023
9
0.190
 Why?
Pain
2
2019
794
0.190
 Why?
Drug Administration Schedule
6
2026
789
0.190
 Why?
Sublingual Immunotherapy
1
2022
4
0.190
 Why?
Young Adult
13
2025
14437
0.190
 Why?
Anxiety
3
2019
1149
0.190
 Why?
Drug Industry
2
2018
49
0.180
 Why?
Receptors, Interleukin
3
2020
43
0.180
 Why?
Animals
17
2024
38410
0.180
 Why?
Tight Junctions
3
2011
86
0.180
 Why?
Sickness Impact Profile
2
2019
67
0.180
 Why?
Cefuroxime
1
2001
5
0.180
 Why?
Cyclopropanes
3
2026
84
0.170
 Why?
Recurrence
4
2019
1151
0.170
 Why?
Skin Cream
3
2026
11
0.170
 Why?
Cephalosporins
1
2001
45
0.170
 Why?
STAT6 Transcription Factor
3
2011
24
0.170
 Why?
Autoantibodies
1
2008
1513
0.160
 Why?
Evidence-Based Medicine
3
2024
742
0.160
 Why?
Depression
3
2019
1599
0.160
 Why?
Bacterial Toxins
3
2012
109
0.160
 Why?
Patient Education as Topic
5
2015
781
0.160
 Why?
Patient Reported Outcome Measures
5
2024
506
0.150
 Why?
Injections, Subcutaneous
4
2023
170
0.150
 Why?
Sleep Initiation and Maintenance Disorders
1
2022
198
0.150
 Why?
Vaccines
1
2024
389
0.140
 Why?
Skin Diseases, Infectious
3
2008
13
0.140
 Why?
Phosphodiesterase Inhibitors
1
2018
73
0.140
 Why?
Patient Health Questionnaire
1
2018
44
0.140
 Why?
Injections
1
2019
200
0.140
 Why?
Gene Expression Regulation
7
2011
2625
0.130
 Why?
Guidelines as Topic
2
2018
268
0.130
 Why?
Surveys and Questionnaires
5
2019
6164
0.130
 Why?
Immunologic Factors
2
2005
261
0.130
 Why?
Genetic Predisposition to Disease
6
2011
2458
0.130
 Why?
Skin Diseases
1
2019
152
0.130
 Why?
T-Lymphocytes
6
2006
2017
0.120
 Why?
Sleep Wake Disorders
1
2021
315
0.120
 Why?
Skin Diseases, Viral
2
2018
6
0.120
 Why?
Drug Therapy, Combination
4
2026
1046
0.120
 Why?
Gloves, Surgical
1
1996
4
0.120
 Why?
Latex
1
1996
9
0.120
 Why?
Gloves, Protective
1
1996
3
0.120
 Why?
Rubber
1
1996
8
0.120
 Why?
Personal Satisfaction
1
2018
221
0.120
 Why?
Cells, Cultured
13
2011
4169
0.120
 Why?
Practice Patterns, Physicians'
2
2017
1379
0.120
 Why?
Dermatitis, Occupational
1
1996
16
0.120
 Why?
Bronchial Hyperreactivity
1
1996
104
0.120
 Why?
Chemokines, CC
3
2006
33
0.110
 Why?
Receptors, Cytokine
2
2010
36
0.110
 Why?
Milk Proteins
1
2015
33
0.110
 Why?
Milk Hypersensitivity
1
2015
18
0.110
 Why?
T-Lymphocyte Subsets
2
2011
421
0.110
 Why?
Patient Acceptance of Health Care
2
2019
895
0.110
 Why?
Primary Health Care
2
2016
1759
0.110
 Why?
Infant Formula
1
2015
71
0.110
 Why?
Hydrotherapy
1
2014
7
0.110
 Why?
Skin Tests
3
2012
94
0.100
 Why?
Patient-Centered Care
2
2018
552
0.100
 Why?
Clinical Decision-Making
1
2018
367
0.100
 Why?
Gene Expression Profiling
4
2011
1794
0.100
 Why?
Patient Care Planning
1
2015
171
0.100
 Why?
HLA-B7 Antigen
1
2013
7
0.100
 Why?
Ambulatory Care
1
2019
625
0.100
 Why?
Recombinant Proteins
6
2006
1371
0.100
 Why?
Dose-Response Relationship, Drug
5
2020
2030
0.100
 Why?
Algorithms
3
2018
1868
0.100
 Why?
Clinical Trials, Phase III as Topic
2
2024
116
0.100
 Why?
Risk Factors
8
2015
11017
0.090
 Why?
Health Status
1
2018
839
0.090
 Why?
Cholecalciferol
1
2013
61
0.090
 Why?
Logistic Models
4
2019
2142
0.090
 Why?
Delphi Technique
2
2024
347
0.090
 Why?
RNA, Messenger
10
2007
2812
0.090
 Why?
Lipids
1
2017
723
0.090
 Why?
Interferon Regulatory Factor-2
1
2011
3
0.090
 Why?
Eosinophils
3
2024
319
0.090
 Why?
Immunity, Cellular
1
2013
280
0.090
 Why?
Vitamins
1
2013
184
0.090
 Why?
Fibronectins
2
2023
136
0.090
 Why?
Aged
13
2019
26514
0.090
 Why?
Research Design
1
2018
1157
0.080
 Why?
Vitamin D
2
2013
405
0.080
 Why?
Mice, Transgenic
3
2011
2197
0.080
 Why?
Polymorphism, Single Nucleotide
7
2011
2223
0.080
 Why?
Pharmaceutical Vehicles
2
2008
12
0.080
 Why?
Physical Therapy Modalities
1
2014
346
0.080
 Why?
Guideline Adherence
1
2015
590
0.080
 Why?
Glucocorticoids
2
2013
537
0.080
 Why?
Th1-Th2 Balance
1
2010
8
0.080
 Why?
JNK Mitogen-Activated Protein Kinases
1
2011
153
0.080
 Why?
Signal Transduction
2
2023
5272
0.080
 Why?
CD4-Positive T-Lymphocytes
3
2010
1162
0.080
 Why?
Receptors, Chemokine
1
2010
48
0.080
 Why?
Chickenpox Vaccine
1
2010
76
0.080
 Why?
Therapies, Investigational
1
2010
19
0.080
 Why?
Receptors, Interleukin-7
1
2010
28
0.080
 Why?
Cathelicidins
5
2010
40
0.080
 Why?
Hypertension
1
2018
1280
0.070
 Why?
Herpesviridae Infections
1
2010
148
0.070
 Why?
Genetic Variation
2
2011
995
0.070
 Why?
Cardiovascular Diseases
2
2018
2218
0.070
 Why?
Adjuvants, Immunologic
3
2004
245
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2011
751
0.070
 Why?
Age Factors
4
2019
3372
0.070
 Why?
Coal Tar
1
2008
2
0.070
 Why?
Keratolytic Agents
1
2008
5
0.070
 Why?
Dietary Supplements
1
2013
586
0.070
 Why?
Cell Degranulation
1
2008
40
0.070
 Why?
Mice
9
2012
18491
0.070
 Why?
Disease Outbreaks
1
2012
420
0.070
 Why?
Polymorphism, Genetic
1
2011
615
0.070
 Why?
Pediatrics
2
2015
1139
0.070
 Why?
Pyroglyphidae
2
2022
18
0.070
 Why?
Basophils
1
2008
52
0.070
 Why?
Irritants
1
2008
42
0.070
 Why?
S100 Proteins
1
2008
35
0.070
 Why?
Dosage Forms
1
2008
11
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2011
1224
0.070
 Why?
Phenotype
4
2023
3216
0.070
 Why?
United Kingdom
2
2019
391
0.060
 Why?
Aged, 80 and over
6
2019
8430
0.060
 Why?
Environmental Exposure
1
2012
583
0.060
 Why?
Combined Modality Therapy
3
2014
1281
0.060
 Why?
Reference Values
2
2019
800
0.060
 Why?
Protein Precursors
1
2007
136
0.060
 Why?
CD8-Positive T-Lymphocytes
1
2013
932
0.060
 Why?
Macrophage Inflammatory Proteins
1
2006
11
0.060
 Why?
Herpesvirus 3, Human
1
2010
343
0.060
 Why?
Mast Cells
1
2008
148
0.060
 Why?
Immunohistochemistry
6
2010
1730
0.060
 Why?
Clinical Protocols
1
2008
284
0.060
 Why?
Cromolyn Sodium
1
2026
6
0.060
 Why?
Disease Susceptibility
2
2020
347
0.060
 Why?
Quality Improvement
1
2016
1321
0.060
 Why?
Drug Combinations
3
2020
399
0.060
 Why?
Patient Dropouts
1
2007
67
0.060
 Why?
Nonprescription Drugs
1
2007
69
0.060
 Why?
Cost-Benefit Analysis
3
2018
653
0.060
 Why?
Lymphocyte Activation
3
2010
1140
0.060
 Why?
Antibodies, Anti-Idiotypic
1
2006
50
0.060
 Why?
Emergency Service, Hospital
1
2019
2416
0.060
 Why?
Receptors, Lymphocyte Homing
1
2006
15
0.060
 Why?
Virus Replication
2
2006
521
0.060
 Why?
Proteins
2
2010
1024
0.060
 Why?
Gene Frequency
3
2013
498
0.060
 Why?
Conjunctivitis, Allergic
1
2025
4
0.060
 Why?
Immunoglobulins
2
2005
163
0.060
 Why?
Thiazoles
1
2006
142
0.060
 Why?
Thyroid Diseases
1
2005
45
0.050
 Why?
Models, Immunological
1
2005
99
0.050
 Why?
L-Lactate Dehydrogenase
1
2024
112
0.050
 Why?
Interleukins
1
2006
248
0.050
 Why?
Academies and Institutes
1
2004
61
0.050
 Why?
Resorcinols
1
2023
6
0.050
 Why?
Immunoglobulin G
2
2023
901
0.050
 Why?
Conflict of Interest
1
2004
55
0.050
 Why?
Stilbenes
1
2023
30
0.050
 Why?
Gene Expression
4
2007
1481
0.050
 Why?
Hyaluronic Acid
1
2006
226
0.050
 Why?
Lactams
2
1995
28
0.050
 Why?
Statistics, Nonparametric
2
2019
430
0.050
 Why?
Interleukin-10
1
2005
311
0.050
 Why?
Janus Kinase 1
1
2023
26
0.050
 Why?
Leukocyte Count
2
1995
319
0.050
 Why?
Nitriles
1
2024
211
0.050
 Why?
Interleukin-11
1
2003
10
0.050
 Why?
STAT Transcription Factors
1
2023
25
0.050
 Why?
Acute Disease
6
2008
1049
0.050
 Why?
Risk
2
2018
927
0.050
 Why?
Membrane Glycoproteins
1
2006
499
0.050
 Why?
Prednisone
2
1994
230
0.050
 Why?
Dermatophagoides pteronyssinus
1
2022
3
0.050
 Why?
Patient Compliance
1
2007
591
0.050
 Why?
Respiratory Sounds
1
2023
103
0.050
 Why?
Azetidines
1
2022
45
0.050
 Why?
Patient Care Team
1
2008
712
0.050
 Why?
Clinical Trials, Phase II as Topic
1
2022
75
0.050
 Why?
Granuloma, Respiratory Tract
1
2002
13
0.050
 Why?
Interleukin-17
1
2003
123
0.050
 Why?
Insurance, Physician Services
1
2002
4
0.050
 Why?
Baths
1
2022
14
0.040
 Why?
Langerhans Cells
1
2001
12
0.040
 Why?
Leukocytes, Mononuclear
3
2013
590
0.040
 Why?
3',5'-Cyclic-AMP Phosphodiesterases
1
2001
8
0.040
 Why?
Prognosis
3
2018
4383
0.040
 Why?
North America
1
2022
307
0.040
 Why?
Superantigens
1
2001
70
0.040
 Why?
Ceramides
1
2022
117
0.040
 Why?
Lymphoma
2
2018
253
0.040
 Why?
Purines
1
2022
188
0.040
 Why?
Interleukin-15
1
2002
97
0.040
 Why?
Prospective Studies
2
2020
8164
0.040
 Why?
Claudin-1
2
2011
17
0.040
 Why?
Immunotherapy
1
2006
672
0.040
 Why?
Prodrugs
1
2001
54
0.040
 Why?
Time Factors
2
2007
7173
0.040
 Why?
Beryllium
1
2002
163
0.040
 Why?
Bacterial Adhesion
1
2001
109
0.040
 Why?
Antigens, Bacterial
1
2001
126
0.040
 Why?
Placebos
1
2021
193
0.040
 Why?
Monocyte Chemoattractant Proteins
1
2000
7
0.040
 Why?
Disease Models, Animal
1
2011
4604
0.040
 Why?
Caregivers
2
2023
1091
0.040
 Why?
Diet
2
2022
1284
0.040
 Why?
Bayes Theorem
1
2022
428
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
3
2011
849
0.040
 Why?
Fibrinogen
1
2001
180
0.040
 Why?
Injection Site Reaction
1
2020
4
0.040
 Why?
Health Expenditures
1
2002
199
0.040
 Why?
Longitudinal Studies
2
2019
3027
0.040
 Why?
Markov Chains
2
2015
132
0.040
 Why?
Chemokines, CXC
2
2003
68
0.040
 Why?
Leg Dermatoses
1
2019
1
0.040
 Why?
Scalp Dermatoses
1
2019
4
0.040
 Why?
Foot Dermatoses
1
2019
4
0.040
 Why?
Buttocks
1
2019
14
0.040
 Why?
Hand Dermatoses
1
2019
7
0.040
 Why?
Facial Dermatoses
1
2019
17
0.040
 Why?
Bronchoalveolar Lavage Fluid
3
2002
641
0.040
 Why?
Biopsy
4
2007
1093
0.040
 Why?
Genitalia
1
2019
33
0.040
 Why?
Genetic Association Studies
2
2011
374
0.040
 Why?
Smallpox Vaccine
2
2011
23
0.040
 Why?
Fatty Acids
1
2022
461
0.040
 Why?
Risk Assessment
2
2019
3784
0.040
 Why?
Torso
1
2019
36
0.040
 Why?
Interleukin-16
1
1998
6
0.040
 Why?
Skin Diseases, Bacterial
1
2018
22
0.040
 Why?
Haplotypes
2
2011
509
0.040
 Why?
Infection Control
1
2020
174
0.040
 Why?
Autoantigens
1
2001
429
0.040
 Why?
Dysbiosis
1
2020
188
0.040
 Why?
Association
1
2018
12
0.040
 Why?
Phthalic Acids
1
2018
43
0.030
 Why?
Thalidomide
1
2018
43
0.030
 Why?
Acetamides
1
2018
42
0.030
 Why?
Rhinitis, Allergic, Seasonal
1
2018
25
0.030
 Why?
Arm
1
2019
110
0.030
 Why?
Canada
1
2020
435
0.030
 Why?
Colony Count, Microbial
1
2018
90
0.030
 Why?
Herpesvirus 2, Human
2
2009
27
0.030
 Why?
Age Distribution
1
2018
406
0.030
 Why?
Sex Distribution
1
2018
390
0.030
 Why?
Medicaid
1
2002
475
0.030
 Why?
Fundoplication
1
1997
52
0.030
 Why?
Immune System
1
2018
181
0.030
 Why?
Quinazolines
1
2018
266
0.030
 Why?
United States Food and Drug Administration
1
2018
208
0.030
 Why?
Peak Expiratory Flow Rate
2
1993
25
0.030
 Why?
Monocytes
2
2002
539
0.030
 Why?
Psychiatric Status Rating Scales
1
2019
537
0.030
 Why?
Pilot Projects
2
1995
1912
0.030
 Why?
Educational Status
1
2019
475
0.030
 Why?
Forced Expiratory Volume
2
1997
451
0.030
 Why?
Texas
2
2008
278
0.030
 Why?
Proteomics
1
2023
1203
0.030
 Why?
Interleukin-12
1
1996
115
0.030
 Why?
Health Occupations
1
1996
36
0.030
 Why?
Genetic Linkage
1
1996
273
0.030
 Why?
Whey Proteins
1
2015
9
0.030
 Why?
Psychometrics
1
2019
739
0.030
 Why?
Vaccination
1
2024
1443
0.030
 Why?
Penicillins
1
1995
65
0.030
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
980
0.030
 Why?
Gastroesophageal Reflux
1
1997
237
0.030
 Why?
Multivariate Analysis
1
2019
1550
0.030
 Why?
Legionellosis
1
1994
2
0.030
 Why?
Legionnaires' Disease
1
1994
4
0.030
 Why?
Nebulizers and Vaporizers
1
1995
63
0.030
 Why?
Dermatitis, Irritant
2
2004
12
0.030
 Why?
Anaphylaxis
1
1996
105
0.030
 Why?
Intraoperative Complications
1
1996
158
0.030
 Why?
Milk
1
2015
119
0.030
 Why?
Polymerase Chain Reaction
2
2010
1046
0.030
 Why?
Pneumonia, Pneumocystis
1
1994
34
0.030
 Why?
Methylprednisolone
1
1994
59
0.030
 Why?
Pyridines
1
2018
610
0.030
 Why?
Attention Deficit Disorder with Hyperactivity
1
2018
434
0.030
 Why?
Socioeconomic Factors
1
2019
1342
0.030
 Why?
Antigens
1
1996
348
0.030
 Why?
Long-Term Care
1
2015
118
0.030
 Why?
Feasibility Studies
1
2018
1147
0.030
 Why?
Cohort Studies
2
2015
6099
0.030
 Why?
Respiratory Physiological Phenomena
1
1993
35
0.020
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1995
161
0.020
 Why?
ROC Curve
1
2015
626
0.020
 Why?
Sleep
1
2021
895
0.020
 Why?
Chemokine CXCL10
2
2009
39
0.020
 Why?
Immunologic Memory
1
1996
370
0.020
 Why?
Case-Control Studies
2
2013
3660
0.020
 Why?
Mice, Inbred BALB C
2
2006
1266
0.020
 Why?
Interdisciplinary Communication
1
2014
201
0.020
 Why?
Sex Factors
1
2019
2136
0.020
 Why?
Genotype
1
2018
1875
0.020
 Why?
Laparoscopy
1
1997
486
0.020
 Why?
Chemokines
2
2006
217
0.020
 Why?
Respiratory System
1
1993
150
0.020
 Why?
Cockroaches
1
2012
23
0.020
 Why?
Treatment Failure
1
1993
360
0.020
 Why?
Haptens
1
1992
25
0.020
 Why?
Healthcare Disparities
1
2019
740
0.020
 Why?
Cats
1
2012
241
0.020
 Why?
Models, Theoretical
1
2015
563
0.020
 Why?
Patient Care
1
2013
121
0.020
 Why?
Vaccinia
1
2011
20
0.020
 Why?
Reproducibility of Results
1
2019
3448
0.020
 Why?
Mice, Knockout
2
2011
3153
0.020
 Why?
Microbiota
1
2019
736
0.020
 Why?
Enterocolitis, Pseudomembranous
1
1991
29
0.020
 Why?
Receptors, Interferon
1
2011
60
0.020
 Why?
Lung Diseases
1
1997
787
0.020
 Why?
Fluorescent Antibody Technique
1
2011
365
0.020
 Why?
Dogs
1
2012
518
0.020
 Why?
Family
1
2015
690
0.020
 Why?
Predictive Value of Tests
1
2015
2133
0.020
 Why?
Cell Line
2
2008
2832
0.020
 Why?
Antigens, Viral
1
2010
186
0.020
 Why?
Chemokine CCL27
1
2009
1
0.020
 Why?
Health Care Costs
2
2003
428
0.020
 Why?
DNA Mutational Analysis
1
2010
414
0.020
 Why?
Mutation
2
2011
4130
0.020
 Why?
Interferon-beta
1
2009
92
0.020
 Why?
Incidence
1
1996
2954
0.020
 Why?
Age of Onset
1
2010
568
0.020
 Why?
Lung
1
2002
4141
0.020
 Why?
Skin Physiological Phenomena
1
2008
24
0.020
 Why?
Herpesvirus 1, Human
1
2009
87
0.020
 Why?
Hospitalization
1
2019
2496
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
106
0.020
 Why?
Glyceraldehyde-3-Phosphate Dehydrogenases
1
2007
12
0.020
 Why?
Fluticasone
1
2007
53
0.020
 Why?
Androstadienes
1
2007
77
0.020
 Why?
Chemokine CCL20
1
2006
5
0.020
 Why?
In Situ Hybridization
2
1998
318
0.020
 Why?
Thiazolidines
1
2006
13
0.010
 Why?
Toll-Like Receptor 3
1
2006
30
0.010
 Why?
Vitis
1
2006
28
0.010
 Why?
Health Personnel
1
2013
762
0.010
 Why?
Apoptosis
1
1995
2454
0.010
 Why?
Antigens, Differentiation, T-Lymphocyte
1
2006
106
0.010
 Why?
Analysis of Variance
1
2008
1302
0.010
 Why?
Europe
1
2006
426
0.010
 Why?
Antibodies, Viral
1
2009
687
0.010
 Why?
Obesity
1
2018
3149
0.010
 Why?
Product Surveillance, Postmarketing
1
2005
74
0.010
 Why?
Erythema
1
2004
28
0.010
 Why?
Neoplasms, Experimental
1
2005
167
0.010
 Why?
Genomics
1
2010
839
0.010
 Why?
Case Management
1
2004
68
0.010
 Why?
Antigens, Neoplasm
1
2006
273
0.010
 Why?
DNA, Viral
1
2006
357
0.010
 Why?
Inflammation Mediators
1
2006
507
0.010
 Why?
Collagen Type III
1
2003
15
0.010
 Why?
Rats
1
2012
5613
0.010
 Why?
Retreatment
1
2003
80
0.010
 Why?
Infant, Newborn
1
2015
6543
0.010
 Why?
Dendritic Cells
1
2006
510
0.010
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.010
 Why?
Base Sequence
1
2006
2175
0.010
 Why?
Collagen Type I
1
2003
145
0.010
 Why?
Immunoblotting
1
2002
296
0.010
 Why?
Insurance, Health, Reimbursement
1
2003
98
0.010
 Why?
Transforming Growth Factor beta1
1
2003
177
0.010
 Why?
Health Services
1
2003
113
0.010
 Why?
Societies, Medical
1
2006
914
0.010
 Why?
Calcium
1
2008
1197
0.010
 Why?
Immunophenotyping
1
2003
325
0.010
 Why?
Administration, Oral
1
2004
874
0.010
 Why?
Biopsy, Needle
1
2002
186
0.010
 Why?
Cooperative Behavior
1
2004
471
0.010
 Why?
Chemotactic Factors, Eosinophil
1
2000
7
0.010
 Why?
Up-Regulation
1
2003
848
0.010
 Why?
Chemokine CCL11
1
2000
25
0.010
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
334
0.010
 Why?
Cell Adhesion Molecules
1
2001
182
0.010
 Why?
Transforming Growth Factor beta
1
2003
475
0.010
 Why?
Extracellular Matrix Proteins
1
2001
156
0.010
 Why?
Cell Differentiation
1
2008
2054
0.010
 Why?
Patient Satisfaction
1
2004
718
0.010
 Why?
Odds Ratio
1
2003
1084
0.010
 Why?
Drug Prescriptions
1
2002
293
0.010
 Why?
Receptors, Interleukin-5
1
1998
4
0.010
 Why?
Receptors, Interleukin-12
1
1998
6
0.010
 Why?
Receptors, Interleukin-4
1
1998
16
0.010
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
1998
17
0.010
 Why?
Amino Acid Sequence
1
2002
2134
0.010
 Why?
Flow Cytometry
1
2002
1172
0.010
 Why?
Molecular Sequence Data
1
2002
2886
0.010
 Why?
Cell Movement
1
2002
966
0.010
 Why?
Models, Biological
1
2004
1772
0.010
 Why?
Retrospective Studies
2
2006
17560
0.010
 Why?
Respiratory Function Tests
1
1997
545
0.010
 Why?
Colorado
1
2006
4591
0.010
 Why?
Immunocompetence
1
1994
46
0.010
 Why?
Interleukin-5
1
1994
39
0.010
 Why?
Methacholine Chloride
1
1993
51
0.010
 Why?
Bronchial Provocation Tests
1
1993
47
0.010
 Why?
Fatal Outcome
1
1994
306
0.010
 Why?
Aerosols
1
1993
147
0.010
 Why?
Interleukin-8
1
1993
269
0.010
 Why?
Macrophage Activation
1
1993
181
0.010
 Why?
Administration, Inhalation
1
1993
572
0.010
 Why?
Bronchi
1
1993
263
0.010
 Why?
Cell Survival
1
1995
1111
0.010
 Why?
Enterotoxins
1
1991
89
0.010
 Why?
Macrophages, Alveolar
1
1993
377
0.000
 Why?
Antibodies, Bacterial
1
1991
148
0.000
 Why?
Immunoglobulins, Intravenous
1
1991
135
0.000
 Why?
Interleukin-1
1
1993
961
0.000
 Why?
Neoplasms
1
2005
2946
0.000
 Why?
Transcription, Genetic
1
1993
1456
0.000
 Why?
Boguniewicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (542) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)